Back
Cadre Holdings Vs. Avidity Biosciences Industry Stock Comparison
Buy
52
CDRE
Cadre Holdings
Last Price:
$34.90
Seasonality Move:
5.03%
Sell
40
RNA
Avidity Biosciences
Last Price:
$32.11
Seasonality Move:
-10.33%
Buy
52
Cadre Holdings (CDRE)
is a Buy
Is Cadre Holdings a Buy, Sell or Hold?
-
The current Cadre Holdings [CDRE] share price is $35.23. The Score for CDRE is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
CDRE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
-
The current Avidity Biosciences [RNA] share price is $32.61. The Score for RNA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
RNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CDRE Stock Price Chart
What is Cadre Holdings's stock price today?
-
The Cadre Holdings share price today is $35.23Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDRE is experiencing buying pressure, which is a positive indicator for future bullish movement.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $32.61The current trend is relatively stagnant and RNA is experiencing buying pressure, which is a positive indicator for future bullish movement.
CDRE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.59 | Sell |
Relative Strength Index (14 RSI): | 55.55 | Buy |
Chaikin Money Flow: | 438969 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.21 - 36.21) | Buy |
Bollinger Bands (100): | (32.87 - 37.35) | Buy |
RNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.46 | Sell |
Relative Strength Index (14 RSI): | 56.94 | Buy |
Chaikin Money Flow: | 1210130 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.71 - 33.63) | Buy |
Bollinger Bands (100): | (29.54 - 43.5) | Sell |
CDRE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 33.36 | Buy |
20-day SMA: | 34.26 | Buy |
50-day SMA: | 34.96 | Buy |
200-day SMA: | 35.12 | Buy |
8-day EMA: | 33.8 | Buy |
20-day EMA: | 34.25 | Buy |
50-day EMA: | 34.87 | Buy |
200-day EMA: | 34.66 | Buy |
RNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.12 | Buy |
20-day SMA: | 31.08 | Buy |
50-day SMA: | 30.94 | Buy |
200-day SMA: | 38.57 | Sell |
8-day EMA: | 30.54 | Buy |
20-day EMA: | 30.84 | Buy |
50-day EMA: | 32.21 | Buy |
200-day EMA: | 34.05 | Sell |
Cadre Holdings Earnings Growth & CDRE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.30 per share, an increase next quarter of $0.08 per share, an increase this year of $0.10 per share, and an increase next year of $0.27 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.13 per share, a decrease this year of $0.97 per share, and a decrease next year of $0.60 per share.
Cadre Holdings Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Avidity Biosciences Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |